In this blog, well explore how Retatrutide works, what makes it different from other weight loss medications, its potential FDA approval timeline, side effects, and more
and Zepbound (tirzepatide), which was approved in 2023 (it was previously available to treat diabetes under the brand name Mounjaro)
Whether you need prescription medications, custom compounding, immunizations, or wellness support, our dedicated team is here to ensure your health needs are met with professionalism and compassion
PubMed, Martchenko, Alexandre, and Patricia Lee Brubaker
As your body adjusts to changes in metabolism, calorie intake, and nutrient balance, more hair follicles may shift into the shedding phase at the same time
Triple agonist mechanism explained Three receptor targets: Retatrutide activates GLP-1 receptors responsible for appetite suppression, insulin secretion enhancement, and gastric emptying delay, similar to semaglutide and other GLP-1 agonists